Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Cholangitis × Midazolam × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 2 Urothelial Cancer 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Neoplasms 1 Nausea 1 Liposarcoma 1 Dyspnea 1 Delirium 1 Death 1 Colorectal Neoplasms 1 Choledocholithiasis 1 Choledochal Cyst 1 Cholangitis 1 Adenocarcinoma of Lung 1

Interventions

Midazolam 1 Meperidine 1 Ketamine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06111872 2025-03-25

Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.

National University of Malaysia

Phase 2 Completed

Gastrointestinal

Cholangitis, Pancreatic Neoplasms, Choledochal Cyst, Choledocholithiasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡